Clinical Trials › NCT06735248
RecruitingPhase 2
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
Sponsored by ModernaTX, Inc.
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 180
Target enrollment
5
U.S. states
Apr 2025
Start date
Jan 2029
Expected completion
Interventions / Treatments
mRNA-1195Placebo
Conditions studied
Multiple Sclerosis
Where this trial is running (8 sites)
Texas3 sites
Dallas · El Paso · Plano
Missouri2 sites
Ozark · St Louis
Massachusetts1 site
Boston
Michigan1 site
Farmington Hills
Oklahoma1 site
Oklahoma City
Participating MS centers on MS Buddy (3)
John L. Trotter Multiple Sclerosis Center
Saint Louis, MO
Saint Louis, MO
OMRF Multiple Sclerosis Center of Excellence
Oklahoma City, OK
Oklahoma City, OK
MS centers in Texas
Compare treatment centers near a trial site by center type, providers and trials.
View Texas centersMore Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.